Paloma Partners’s Dare Bioscience DARE Stock Holding History

Paloma Partners’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,075	Closed	-$9K	–	1729
2018 Q4	$9K	Buy	+1,075	New	+$11.3K	﹤0.01%	1201

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Paloma Partners's DARE Position: Q1 2019 in Review

Paloma Partners sold out of Dare Bioscience (DARE) in Q1 2019, closing a stake of 1,075 shares — an estimated $9K sold.

Paloma Partners first reported a position in DARE in Q4 2018 and held it in 1 quarter. The position peaked at $9K in Q4 2018. 14 funds tracked by Wall St. Rank hold DARE as of Q1 2019.

Paloma Partners reported no remaining Dare Bioscience position as of Q1 2019 after selling out during the quarter.
Paloma Partners sold 1,075 Dare Bioscience shares in Q1 2019, an estimated $9K.
Paloma Partners first reported a position in Dare Bioscience in Q4 2018 and held it in 1 quarter.
Paloma Partners's Dare Bioscience position peaked at $9K in Q4 2018.
14 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2019.

Based on Paloma Partners's 13F filing for Q1 2019, filed 15 May 2019.